Waltham, MA-based clinical trial imaging services provider Voiant and Dutch AI software developer Thirona have entered a global commercial partnership.
The partnership combines Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's AI software for lung image analysis. The companies will offer an integrated platform designed to deliver precise imaging endpoints in trials.
Voiant's network includes more than 400 certified clinical trial sites, while Thirona's software products include algorithms for chest CT image analysis.
